A new US government deal with drugmakers Eli Lilly and Novo Nordisk will slash prices for popular weight-loss drugs like Ozempic and Wegovy. Starting in 2026, some versions could cost just $149 monthly via a new platform. Medicare enrollees with specific health risks will see a $50 copay, making these treatments more accessible and potentially reducing long-term healthcare costs.from LifeStyle - Latest Lifestyle News, Hot Trends, Celebrity Styles & Events https://ift.tt/wk4MKEH
Comments
Post a Comment